Caitong International Asset Management Co., LTD Autolus Therapeutics PLC Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 1,172 shares of AUTL stock, worth $2,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,172
Previous 1,172
-0.0%
Holding current value
$2,390
Previous $2.75 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AUTL
# of Institutions
114Shares Held
160MCall Options Held
2.8KPut Options Held
89.9K-
Wellington Management Group LLP Boston, MA25.3MShares$51.7 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$41.8 Million0.24% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$33.9 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$29 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$20.2 Million0.34% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $185M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...